Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Depreciation & Amortization history
Currency unavailable · from the cash flow
No Depreciation & Amortization data reported for this period type.
Depreciation & Amortization vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $12.55M USD | +33.8% | +20.3% | 17.7% | |
| LTM Mar 2026 | $7.81M USD | -13.0% | +11.0% | 3469.8% | |
| FY2025 | $323K USD | — | — | 1.7% | |
| LTM Jun 2026 | $244K USD | +38.6% | +190.2% | 3.4% | |
| LTM Mar 2026 | $47.85K USD | +47.9% | +108.0% | — | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +36.2% | +64.2% | 10.6% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.